Guy Lerner - Nextage Therapeutics CEO
MCTC Stock | ILA 37.70 1.30 3.33% |
CEO
Mr. Guy Lerner was appointed Chief Executive Officer at Micromedic Technologies Ltd effective July 17, 2016. His work experience includes the role of Chief Executive Officer at Neetour Medical Ltd for six years. He holds a Bachelors degree in Economics from Tel Aviv University and a MBA degree from Pace University. since 2016.
Age | 50 |
Tenure | 8 years |
Professional Marks | MBA |
Phone | 972 73 2753450 |
Web | http://www.m-medic.com |
Nextage Therapeutics Management Efficiency
The company has return on total asset (ROA) of (0.3684) % which means that it has lost $0.3684 on every $100 spent on assets. This is way below average. Nextage Therapeutics' management efficiency ratios could be used to measure how well Nextage Therapeutics manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
Showing other executives | CEO Age | ||
Ehud Arnon | Israel Discount Bank | 65 | |
Lilach Toplinsky | Israel Discount Bank | 48 | |
Arnon Toren | Azrieli Group | 60 | |
Shmuel Antzel | Delek Group | 57 | |
CecileEsther Eldan | Delek Group | 63 | |
Dina Navot | Mizrahi Tefahot | ||
Eyal Lapidot | Delek Group | 52 | |
Israel Keren | Azrieli Group | 76 | |
Nathan Haitchook | Alony Hetz Properties | 65 | |
Romano Vaisenberger | Gazit Globe | 43 | |
Eitan Zeev | Big Shopping Centers | 66 | |
Asaf Bartfeld | Delek Group | 66 | |
Eyal Chenkin | Azrieli Group | 47 | |
Yuval Bronstein | Azrieli Group | 47 | |
Esther Deutsch | Israel Discount Bank | 57 | |
Yehuda Milstein | Big Shopping Centers | 45 | |
Israel Yaaqovi | Big Shopping Centers | 56 | |
Yosef Abu | Delek Group | 40 | |
Eyal Hankin | Azrieli Group | N/A | |
Rakefet RussakAminoach | Bank Leumi Le Israel | 51 | |
Daniel Tsiddon | Bank Leumi Le Israel | 59 |
Management Performance
Return On Asset | -0.37 |
Nextage Therapeutics Leadership Team
Elected by the shareholders, the Nextage Therapeutics' board of directors comprises two types of representatives: Nextage Therapeutics inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Nextage. The board's role is to monitor Nextage Therapeutics' management team and ensure that shareholders' interests are well served. Nextage Therapeutics' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Nextage Therapeutics' outside directors are responsible for providing unbiased perspectives on the board's policies.
Meir Yoeli, Chief Executive Officer | ||
Itai BarNatan, Chief Officer | ||
Guy Lerner, CEO | ||
Yifftach Biel, Deputy Vice President - Finance | ||
Yael Glickman, VP Devel | ||
Doron Debbie, Independent Director |
Nextage Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Nextage Therapeutics a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Asset | -0.37 | |||
Profit Margin | (2.30) % | |||
Operating Margin | (9.71) % | |||
Shares Outstanding | 2.27 M | |||
Shares Owned By Insiders | 22.39 % | |||
Shares Owned By Institutions | 0.02 % | |||
Price To Earning | (91.98) X | |||
Price To Book | 4.68 X | |||
Price To Sales | 26.11 X | |||
Revenue | 297 K |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Nextage Therapeutics. Also, note that the market value of any Company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.
Complementary Tools for Nextage Stock analysis
When running Nextage Therapeutics' price analysis, check to measure Nextage Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nextage Therapeutics is operating at the current time. Most of Nextage Therapeutics' value examination focuses on studying past and present price action to predict the probability of Nextage Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nextage Therapeutics' price. Additionally, you may evaluate how the addition of Nextage Therapeutics to your portfolios can decrease your overall portfolio volatility.
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk |